Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9AT17
Term | Name | Level | Count |
---|---|---|---|
GO:0005488 | binding | 1 | 5 |
GO:0005509 | calcium ion binding | 5 | 5 |
GO:0043167 | ion binding | 2 | 5 |
GO:0043169 | cation binding | 3 | 5 |
GO:0046872 | metal ion binding | 4 | 5 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 144 | 146 | PF00675 | 0.564 |
CLV_NRD_NRD_1 | 293 | 295 | PF00675 | 0.553 |
CLV_PCSK_KEX2_1 | 144 | 146 | PF00082 | 0.564 |
CLV_PCSK_KEX2_1 | 32 | 34 | PF00082 | 0.554 |
CLV_PCSK_PC1ET2_1 | 32 | 34 | PF00082 | 0.397 |
CLV_PCSK_SKI1_1 | 172 | 176 | PF00082 | 0.396 |
CLV_PCSK_SKI1_1 | 179 | 183 | PF00082 | 0.347 |
DEG_APCC_DBOX_1 | 239 | 247 | PF00400 | 0.403 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.421 |
DOC_MAPK_FxFP_2 | 195 | 198 | PF00069 | 0.316 |
DOC_PP2B_LxvP_1 | 324 | 327 | PF13499 | 0.493 |
DOC_PP4_FxxP_1 | 195 | 198 | PF00568 | 0.316 |
DOC_USP7_MATH_1 | 13 | 17 | PF00917 | 0.369 |
DOC_USP7_MATH_1 | 327 | 331 | PF00917 | 0.602 |
DOC_USP7_UBL2_3 | 319 | 323 | PF12436 | 0.531 |
DOC_WW_Pin1_4 | 124 | 129 | PF00397 | 0.454 |
LIG_14-3-3_CanoR_1 | 263 | 268 | PF00244 | 0.461 |
LIG_BRCT_BRCA1_1 | 69 | 73 | PF00533 | 0.380 |
LIG_Clathr_ClatBox_1 | 139 | 143 | PF01394 | 0.421 |
LIG_CtBP_PxDLS_1 | 198 | 202 | PF00389 | 0.396 |
LIG_FHA_1 | 20 | 26 | PF00498 | 0.481 |
LIG_FHA_2 | 100 | 106 | PF00498 | 0.286 |
LIG_FHA_2 | 181 | 187 | PF00498 | 0.346 |
LIG_FHA_2 | 237 | 243 | PF00498 | 0.377 |
LIG_FHA_2 | 70 | 76 | PF00498 | 0.481 |
LIG_Integrin_RGD_1 | 184 | 186 | PF01839 | 0.356 |
LIG_LIR_Apic_2 | 207 | 211 | PF02991 | 0.480 |
LIG_LIR_Gen_1 | 70 | 79 | PF02991 | 0.479 |
LIG_LIR_Nem_3 | 227 | 233 | PF02991 | 0.356 |
LIG_LIR_Nem_3 | 70 | 76 | PF02991 | 0.480 |
LIG_PTB_Apo_2 | 272 | 279 | PF02174 | 0.470 |
LIG_PTB_Phospho_1 | 272 | 278 | PF10480 | 0.467 |
LIG_REV1ctd_RIR_1 | 318 | 326 | PF16727 | 0.383 |
LIG_SH2_CRK | 313 | 317 | PF00017 | 0.520 |
LIG_SH2_PTP2 | 208 | 211 | PF00017 | 0.412 |
LIG_SH2_SRC | 37 | 40 | PF00017 | 0.254 |
LIG_SH2_SRC | 88 | 91 | PF00017 | 0.473 |
LIG_SH2_STAP1 | 132 | 136 | PF00017 | 0.379 |
LIG_SH2_STAP1 | 219 | 223 | PF00017 | 0.410 |
LIG_SH2_STAP1 | 88 | 92 | PF00017 | 0.538 |
LIG_SH2_STAT3 | 309 | 312 | PF00017 | 0.543 |
LIG_SH2_STAT5 | 194 | 197 | PF00017 | 0.435 |
LIG_SH2_STAT5 | 208 | 211 | PF00017 | 0.480 |
LIG_SH2_STAT5 | 230 | 233 | PF00017 | 0.408 |
LIG_SH2_STAT5 | 34 | 37 | PF00017 | 0.458 |
LIG_SH3_3 | 117 | 123 | PF00018 | 0.431 |
LIG_SH3_3 | 144 | 150 | PF00018 | 0.404 |
LIG_SH3_3 | 174 | 180 | PF00018 | 0.298 |
LIG_SUMO_SIM_par_1 | 22 | 29 | PF11976 | 0.463 |
LIG_UBA3_1 | 168 | 175 | PF00899 | 0.453 |
LIG_UBA3_1 | 273 | 280 | PF00899 | 0.443 |
LIG_WRC_WIRS_1 | 301 | 306 | PF05994 | 0.542 |
MOD_CK1_1 | 157 | 163 | PF00069 | 0.541 |
MOD_CK1_1 | 262 | 268 | PF00069 | 0.532 |
MOD_CK2_1 | 69 | 75 | PF00069 | 0.459 |
MOD_CK2_1 | 99 | 105 | PF00069 | 0.421 |
MOD_GlcNHglycan | 152 | 155 | PF01048 | 0.714 |
MOD_GlcNHglycan | 159 | 162 | PF01048 | 0.636 |
MOD_GlcNHglycan | 199 | 204 | PF01048 | 0.373 |
MOD_GlcNHglycan | 282 | 285 | PF01048 | 0.533 |
MOD_GlcNHglycan | 49 | 52 | PF01048 | 0.429 |
MOD_GSK3_1 | 150 | 157 | PF00069 | 0.658 |
MOD_GSK3_1 | 219 | 226 | PF00069 | 0.325 |
MOD_GSK3_1 | 259 | 266 | PF00069 | 0.414 |
MOD_GSK3_1 | 327 | 334 | PF00069 | 0.515 |
MOD_GSK3_1 | 43 | 50 | PF00069 | 0.549 |
MOD_LATS_1 | 298 | 304 | PF00433 | 0.461 |
MOD_N-GLC_1 | 19 | 24 | PF02516 | 0.423 |
MOD_PIKK_1 | 122 | 128 | PF00454 | 0.387 |
MOD_PKA_1 | 279 | 285 | PF00069 | 0.515 |
MOD_PKA_2 | 211 | 217 | PF00069 | 0.453 |
MOD_PKA_2 | 262 | 268 | PF00069 | 0.438 |
MOD_PKA_2 | 52 | 58 | PF00069 | 0.480 |
MOD_Plk_1 | 219 | 225 | PF00069 | 0.358 |
MOD_Plk_1 | 99 | 105 | PF00069 | 0.423 |
MOD_Plk_4 | 132 | 138 | PF00069 | 0.359 |
MOD_Plk_4 | 263 | 269 | PF00069 | 0.494 |
MOD_Plk_4 | 99 | 105 | PF00069 | 0.450 |
MOD_ProDKin_1 | 124 | 130 | PF00069 | 0.455 |
TRG_ENDOCYTIC_2 | 230 | 233 | PF00928 | 0.326 |
TRG_ENDOCYTIC_2 | 313 | 316 | PF00928 | 0.521 |
TRG_Pf-PMV_PEXEL_1 | 172 | 176 | PF00026 | 0.323 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PBZ0 | Leptomonas seymouri | 71% | 98% |
A0A1X0NFQ9 | Trypanosomatidae | 43% | 100% |
A0A3Q8IH99 | Leishmania donovani | 93% | 100% |
A0A3R7N4F8 | Trypanosoma rangeli | 43% | 100% |
A4HPA6 | Leishmania braziliensis | 81% | 100% |
A4IDL4 | Leishmania infantum | 94% | 100% |
D0A3B4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 42% | 100% |
Q4Q1I1 | Leishmania major | 93% | 100% |